Quantcast

Baltimore-based Cerecor announces deal with Merck

Cerecor Inc., of Baltimore, a development-stage biotechnology company, said it has agreed to acquire potential treatments for Parkinson's disease and other central nervous system disorders from Merck & Co.

Leave a Reply

Your email address will not be published. Required fields are marked *

*